William Blair & Company LLC

04/28/2025 | Press release | Distributed by Public on 04/28/2025 09:01

Armira Has Partnered With Osypka AG

William Blair acted as the exclusive M&A advisor to Armira on its partnership with Osypka AG. The transaction closed on April 9, 2025.

About the Companies

Armira is a Munich-based investment holding company focused on direct equity investments in medium-sized, profitable family businesses as well as resilient growth companies in the DACH region, Italy, and beyond. Backed by an exclusive investor base of entrepreneurs and families, Armira offers capital and strategic support with a long-term perspective.

Osypka AG is an internationally recognised provider and partner for innovative medical technology, offering advanced products for interventional and pediatric cardiology as well as cardiac surgery, providing global contract partners with technically and qualitatively sophisticated turnkey CDMO solutions, particularly in electrically active implants and neurostimulation. Since its founding in 1977 by Prof. Dr. Peter Osypka, the company has stood for technical excellence, improving the quality of life and care for patients worldwide.

Learn more about our medical technology investment banking expertise.

William Blair & Company LLC published this content on April 28, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 28, 2025 at 15:01 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]